MedPath

Telerehabilitation in Mild Cognitive Impairment

Not Applicable
Completed
Conditions
Mild Cognitive Impairment
Registration Number
NCT03486704
Lead Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brief Summary

The main aim of the study is to evaluate the efficacy of the Virtual Reality Rehabilitation System (VRRS) compared to usual care treatment for patients with Mild Cognitive Impairment (MCI). Moreover, we will assess the possibility to prolong the beneficial effects of the treatment with an innovative telerehabilitation system. In the second phase of the present study we aim to evaluate the short and long term effects induced by the treatment of active (anodal) transcranial Direct Current Stimulation (tDCS) applied to the left dorsolateral prefrontal cortex combined with VRRS compared to placebo tDCS stimulation combined with VRRS.

The effects of the intervention on outcome variables will be assessed using a randomized controlled trial design with five groups. The investigators will assess the effects of VRRS system and of the implementation of the at-home treatment on the quality of life, cognitive and functional abilities.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Diagnosis of MCI, defined according to standard criteria (Petersen et al., 2011)
  • Mini Mental State Examination (MMSE) ≥24
  • Education ≥ 5 years
  • All of the subjects will have normal or corrected-to-normal vision and will be native Italian speakers.
  • All participants reported subjective memory complaints and objective memory impairment, but no impairment of function in daily life.
Exclusion Criteria
  • visual perception disorder and/or hearing loss
  • history of major psychiatric disorders
  • any contraindication for tDCS such as a history of seizures, major head trauma, past brain surgery, a brain metal implant or a pacemaker.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in long term episodic verbal memoryBaseline up to 12 weeks and 4 and 7 months

Auditory Verbal Learning Test, immediate and delayed recall

Secondary Outcome Measures
NameTimeMethod
Change in measure of quality of lifeBaseline up to 12 weeks and 4 and 7 months

Quality of Life in Alzheimer's Disease (AD) - QoL-AD

Change in global cognitionBaseline up to 12 weeks and 4 and 7 months

Mini Mental State Examination (MMSE)

Change in nonverbal long term memoryBaseline up to 12 weeks and 4 and 7 months

Rey-Osterrieth Figure Recall

Change in visual attention and task switchingBaseline up to 12 weeks and 4 and 7 months

Trail Making Test

Change in naming abilitiesBaseline up to 12 weeks and 4 and 7 months

Object and action naming subtests of the Battery for the Analysis of the Aphasic Deficit

Change in dementia severityBaseline up to 12 weeks and 4 and 7 months

Clinical Dementia Rating scale (CDR)

Change in memory complaintsBaseline up to 12 weeks and 4 and 7 months

Everyday Memory Questionnaire (EMQ)

Change in non-verbal abstract reasoningBaseline up to 12 weeks and 4 and 7 months

Raven's Colored Progressive Matrices

Change in verbal fluencyBaseline up to 12 weeks and 4 and 7 months

Phonemic verbal fluency and semantic verbal fluency

Change in visual constructional abilitiesBaseline up to 12 weeks and 4 and 7 months

Rey-Osterrieth Figure Copy

Trial Locations

Locations (1)

IRCCS Centro san Giovanni di Dio

🇮🇹

Brescia, BS, Italy

IRCCS Centro san Giovanni di Dio
🇮🇹Brescia, BS, Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.